Regression of oral proliferative leukoplakia following initiation of ibrutinib therapy in two allogeneic hematopoietic stem cell transplant recipients

Bone Marrow Transplant. 2020 Sep;55(9):1844-1846. doi: 10.1038/s41409-020-0889-2. Epub 2020 Apr 9.

Paolo J Fantozzi^{1

2}, Alessandro Villa³, Joseph H Antin⁴, Nathaniel Treister^{5

6}

¹ Division of Oral Medicine and Dentistry, Brigham and Women's Hospital, Boston, MA, USA. paolojfantozzi@gmail.com.
² Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, MA, USA. paolojfantozzi@gmail.com.
³ Department of Orofacial Sciences, University of California San Francisco, San Francisco, CA, USA.
⁴ Department of Medical Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA.
⁵ Division of Oral Medicine and Dentistry, Brigham and Women's Hospital, Boston, MA, USA.
⁶ Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, MA, USA.

No abstract available

Publication types